Abbott sues DexCom over glucose monitoring system
DexCom has said that it believes the complaint to be without merit, and it intends to “vigorously contest the action”. In a statement DexCom remarked. “DexCom…believes the complaint
China-based Biocytogen Pharmaceuticals has entered a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.